M&A Deal Summary |
|
|---|---|
| Date | 2015-10-01 |
| Target | Representaciones e Investigaciones Medicas S.A. de C.V. |
| Sector | Life Science |
| Buyer(s) | Teva Pharmaceutical Industries |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.3B USD |
| Advisor(s) | Goldman Sachs (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1901 |
| Sector | Life Science |
| Employees | 35,001 |
| Revenue | 15.8B USD (2023) |
Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 23 |
| Sector (Life Science) | 20 of 20 |
| Type (Add-on Acquisition) | 19 of 19 |
| Country (Mexico) | 1 of 1 |
| Year (2015) | 5 of 5 |
| Size (of disclosed) | 8 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-09-25 |
Gecko Health Innovations
Cambridge, Massachusetts, United States Gecko Health Innovations, Inc. is a provider of a cloud-based solution designed to simplify chronic respiratory disease management, connecting patients and caregivers through remote monitoring and real-time adherence tools. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-21 |
Teva Pharmaceutical Industries - Generic Products
Petach Tikva, Israel Teva Pharmaceutical Industries Ltd. - Generic Products includes solid oral, inhalable, injectable and topical dosage forms and the return to Impax of its rights to its pending abbreviated new drug application ("ANDA") for the generic equivalent to Concerta. |
Sell | $586M |
